Within this framework, integrin β3 (ITGB3) emerges as a critical extracellular matrix receptor that orchestrates tumor cell adhesion, survival, and drug resistance in cancers like glioblastoma and breast cancer, often through enhanced survival signaling [17, 18]. The gene discussed is ITGB3; the disease is neoplasm.